Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02285985
What this trial is testing

Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Phoenix VA Health Care System 103
Not applicableUnknownNCT02002143
What this trial is testing

GMVs in Primary Care: An RCT of Group-Based Versus Individual Appointments to Reduce HbA1c in Older People

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University of British Columbia 128
Not applicableLooking for participantsNCT07250789
What this trial is testing

Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)

Who this might be right for
DiabetesDiabetes Mellitus Type 2Type 2 Diabetes+3 more
Steno Diabetes Center Copenhagen 420
Post-approval studies (Phase 4)Study completedNCT02467920
What this trial is testing

Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Huazhong University of Science and Technology 349
Not applicableUnknownNCT01301196
What this trial is testing

Reducing Sedentary Behaviour in Young Adults at Risk of Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Loughborough University 189
Post-approval studies (Phase 4)Study completedNCT01779596
What this trial is testing

ET-blockade and Exercise Induced Blood Flow in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Radboud University Medical Center 22
Post-approval studies (Phase 4)WithdrawnNCT01334203
What this trial is testing

A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Angina PectorisCoronary Artery DiseaseType 2 Diabetes Mellitus
Gilead Sciences
Early research (Phase 1)UnknownNCT05996380
What this trial is testing

Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes

Who this might be right for
T2DM
Jiangsu HengRui Medicine Co., Ltd. 52
Not applicableNot Yet RecruitingNCT07099742
What this trial is testing

Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Obesity
Dr. Md. Alimur Reza 364
Testing effectiveness (Phase 2)Study completedNCT01407003
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 138
Not applicableStudy completedNCT07327086
What this trial is testing

Serum Chromium, Nickel, and Magnesium in Type 2 Diabetic Periodontitis

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Periodontal Disease
Kahramanmaras Sutcu Imam University 74
Post-approval studies (Phase 4)Study completedNCT01212913
What this trial is testing

Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 161
Testing effectiveness (Phase 2)UnknownNCT01342042
What this trial is testing

The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 36
Large-scale testing (Phase 3)Study completedNCT05680129
What this trial is testing

Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Who this might be right for
T2DMType 2 Diabetes Mellitus
Hangzhou Sciwind Biosciences Co., Ltd. 623
Early research (Phase 1)Looking for participantsNCT06884059
What this trial is testing

Time Restricted Eating in Patients With Microalbuminuria

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Time Restricted EatingMicroalbuminuria
University of California, San Diego 25
Early research (Phase 1)Looking for participantsNCT06562907
What this trial is testing

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Weight Management
Gilead Sciences 134
Not applicableLooking for participantsNCT06923644
What this trial is testing

Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases

Who this might be right for
Obesity and OverweightPre-diabeticType 2 Diabetes Mellitus (T2DM)
Maastricht University Medical Center 240
Not applicableEnrolling By InvitationNCT06906653
What this trial is testing

Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy

Who this might be right for
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 Diabetes (T2D)
Kaiser Permanente 204
Not applicableLooking for participantsNCT07184775
What this trial is testing

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)PregnancyContinuous Glucose Monitoring System
Thomas Jefferson University 70
Post-approval studies (Phase 4)Study completedNCT02024477
What this trial is testing

Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients

Who this might be right for
Type 2 Diabetes
George Washington University 42
Next Page